| SC 13G | 2018-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Wave Life Sciences Ltd. | 1,726,956 | 6.2% | EDGAR |
| SC 13G | 2018-02-14 | Redmile Group, LLC | Wave Life Sciences Ltd. | 2,209,107 | 8.0% | EDGAR |
| SC 13G/A | 2018-02-13 | FMR LLC | Wave Life Sciences Ltd. | 1,108,649 | 4.0% | EDGAR |
| SC 13D/A | 2017-11-15 | RA CAPITAL MANAGEMENT, LLC | Wave Life Sciences Ltd. | 7,512,049 | 27.0% | EDGAR |
| SC 13D/A | 2017-09-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Wave Life Sciences Ltd. | 1,384,700 | 5.0% | EDGAR |
| SC 13D/A | 2017-03-31 | Kagoshima Shinsangyo Sousei Investment Limited Partnership | Wave Life Sciences Ltd. | 2,794,865 | 11.9% | EDGAR |
| SC 13G/A | 2017-02-14 | FMR LLC | Wave Life Sciences Ltd. | 1,893,756 | 8.1% | EDGAR |
| SC 13G/A | 2017-02-14 | Foresite Capital Fund III, L.P. | Wave Life Sciences Ltd. | 676,128 | 2.9% | EDGAR |
| SC 13D/A | 2016-09-29 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 21.5% | EDGAR |
| SC 13D/A | 2016-07-26 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 21.5% | EDGAR |
| SC 13G | 2016-05-12 | PFIZER INC | Wave Life Sciences Ltd. | 1,875,000 | 8.0% | EDGAR |
| SC 13G/A | 2016-02-12 | Foresite Capital Fund III, L.P. | Wave Life Sciences Ltd. | 1,410,689 | 6.5% | EDGAR |
| SC 13G | 2016-02-12 | FMR LLC | Wave Life Sciences Ltd. | 2,057,632 | 9.8% | EDGAR |
| SC 13D | 2015-12-10 | TEVA PHARMACEUTICAL INDUSTRIES LTD | Wave Life Sciences Ltd. | 1,875,000 | 9.0% | EDGAR |
| SC 13D | 2015-11-27 | RA CAPITAL MANAGEMENT, LLC | Wave Life Sciences Ltd. | 7,088,651 | 33.9% | EDGAR |
| SC 13D | 2015-11-25 | Kagoshima Shinsangyo Sousei Investment Limited Partnership | Wave Life Sciences Ltd. | 3,228,690 | 15.4% | EDGAR |
| SC 13D | 2015-11-25 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 23.7% | EDGAR |
| SC 13G | 2015-11-19 | Foresite Capital Fund III, L.P. | Wave Life Sciences Ltd. | 1,333,725 | 6.4% | EDGAR |